About PenMed
PenMed is a company based in Truro (United Kingdom) founded in 2018 by Simon Cooke and Seb Brown. PenMed has raised $249.85 thousand across 1 funding round from investors including Cornwall & Isles of Scilly Investment Fund. PenMed offers products and services including P3. PenMed operates in a competitive market with competitors including Noccarc, OneBreath, Inbentus, Dipneo and Flight Medical, among others.
- Headquarter Truro, United Kingdom
- Founders Simon Cooke, Seb Brown
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Peninsula Medical Technologies Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$249.85 K (USD)
in 1 rounds
-
Latest Funding Round
$249.85 K (USD), Seed
Apr 29, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PenMed
PenMed offers a comprehensive portfolio of products and services, including P3.
Modular device for improving efficiency and safety in critical care.
Funding Insights of PenMed
PenMed has successfully raised a total of $249.85K through 1 strategic funding round. The most recent funding activity was a Seed round of $249.85 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PenMed
PenMed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Cornwall & Isles of Scilly Investment Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided to SMEs in Cornwall and Isles of Scilly.
|
Locked | Locked | Locked |
Investor details for PenMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PenMed
Investment portfolio details for PenMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PenMed
Detailed financials for PenMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Penmed Comparisons
Peer comparison for PenMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PenMed
PenMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noccarc, OneBreath, Inbentus, Dipneo and Flight Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart ventilators for respiratory care in ICUs are developed.
|
|
| Locked | Locked | Locked |
Portable mechanical ventilators for intensive care patients are developed.
|
|
| Locked | Locked | Locked |
Hospital medical equipment is developed for ICU applications.
|
|
| Locked | Locked | Locked |
Automatic resuscitation devices are developed for out-of-hospital cardiac arrests.
|
|
| Locked | Locked | Locked |
Portable life-supporting respiratory ventilators are manufactured for various care settings.
|
Detailed competitors of PenMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Penmed
Complete news archive for PenMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PenMed
PenMed was founded in 2018 and raised its 1st funding round 6 years after it was founded.
PenMed is headquartered in Truro, United Kingdom. It is registered at Truro, Cornwall, United Kingdom.
PenMed is a funded company, having raised a total of $249.85K across 1 funding round to date.
PenMed was founded in 2018 in Truro, United Kingdom, within the medical technology sector. Critical care devices are developed by the company to support patient safety and outcomes in intensive care units. Operations focus on state-of-the-art technologies for the P3, a modular anaesthesia and ventilator system designed for efficiency in high-risk environments. The company is led by co-founders Simon Cooke and Seb Brown.
PenMed offers P3.
PenMed has 1 investor. Key investors include Cornwall & Isles of Scilly Investment Fund.